Breaking

cancer

Young, Low-Income Women Face Breast Cancer Treatment Delays
Longevity Lab

Young, Low-Income Women Face Breast Cancer Treatment Delays

Young, low-income women face breast cancer treatment delays, with research showing they're more likely to experience delays at multiple stages of care.

Grace Morrison · October 13, 2026
NR supplement fails to slow Parkinson’s disease in major trial
Longevity Lab

NR supplement fails to slow Parkinson’s disease in major trial

An NR supplement failed to slow Parkinson's disease progression in a major Phase III trial, according to JAMA research.

Olivia Gagnon · October 10, 2026
Enzyme FAH may predict CDK4/6 inhibitor resistance in breast cancer
Gut Check

Enzyme FAH may predict CDK4/6 inhibitor resistance in breast cancer

The enzyme FAH may predict resistance to CDK4/6 inhibitors in hormone receptor-positive breast cancer, offering potential for better treatment strategies.

Olivia Gagnon · October 8, 2026
Cancer Risk Gap Widens for Type 2 Diabetes Patients
Longevity Lab

Cancer Risk Gap Widens for Type 2 Diabetes Patients

A Danish study reveals type 2 diabetes patients face over twice the cancer risk, with the disparity growing significantly in recent years,…

Zoe Cooper · September 23, 2026
Tumor Blood Vessel Profiles Predict Colorectal Cancer Survival
Longevity Lab

Tumor Blood Vessel Profiles Predict Colorectal Cancer Survival

New research into tumor blood vessels may predict colorectal cancer survival outcomes, analyzing 837 patients to identify prognostic blood vessel patterns.

Olivia Gagnon · September 22, 2026
New CRISPR Tool Finds Genes Behind Lymphoma Drug Resistance
Recovery Mode

New CRISPR Tool Finds Genes Behind Lymphoma Drug Resistance

A new CRISPR tool identifies genes behind lymphoma drug resistance, offering new therapeutic targets for fighting cancer progression.

Olivia Gagnon · September 21, 2026
Tumors Hide p53 Mutations from T Cells, Study Finds
Recovery Mode

Tumors Hide p53 Mutations from T Cells, Study Finds

Tumors can hide p53 mutations from T cells, posing challenges for personalized immunotherapy. Researchers find tumors conceal p53 neoantigens, making detection

Olivia Gagnon · September 19, 2026
Chemotherapy Leaves Lasting Damage in Healthy Tissues
Recovery Mode

Chemotherapy Leaves Lasting Damage in Healthy Tissues

Chemotherapy causes lasting damage in healthy tissues, leading to DNA damage in children.

Olivia Gagnon · September 11, 2026